Skip to main content

Bynfezia Pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen Images

Generic Name: octreotide

This medication has been identified as Bynfezia Pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen. It is supplied by Sun Pharmaceutical Industries Inc.

Bynfezia Pen is used in the treatment of Carcinoid Tumor; Acromegaly; Vasoactive Intestinal Peptide Tumor and belongs to the drug class somatostatin and somatostatin analogs. There is no proven risk in humans during pregnancy. Bynfezia Pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Bynfezia pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen medicine

Bynfezia Pen

Generic Name
octreotide
Strength
7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen
Availability
Prescription only
Drug Class
Somatostatin and somatostatin analogs
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
62756-0452

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.